NCT00005001View on ClinicalTrials.gov

Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
BIOLOGICAL

HIV-1 Immunogen

Trial Locations (1)

92121

Agouron Pharmaceuticals Inc, San Diego

Sponsors
All Listed Sponsors
lead

Agouron Pharmaceuticals

INDUSTRY